DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Research & Reports

Searching in Biopharma (1990)

41 Biopharma Reports

  • chronic obstructive pulmonary disease
Long-acting beta2 agonist (LABA)/long-acting muscarinic antagonist (LAMA) fixed-...
Long-acting beta2 agonist (LABA)/long-acting muscarinic antagonist (LAMA) fixed-dose combinations (FDCs) have the potential to be first-line chronic obstructive pulmonary disorder (COPD) therapies,......
1 - 20 of 41